SIAPS Cameroon’s Closing Ceremony Event took place on the 25th of August 2016 in Yaoundé. It was chaired by the Permanent Secretary of the Ministry of Health, Profesor Koulla-Shiro, and accompanied by the General Inspector of the Ministry of Health, Professeur Biwole Sida, the US Embassy Deputy Chief of Mission, Mr. David Brownstein, the Permanent Secretary … Read more
Archive antiretroviral
Baseline Study Report: Prescription Practices for Antiretroviral Therapy in Comprehensive Care Services of the Dominican Republic
The purpose of this study is to determine if the current prescription practices adhere to the national therapeutic guidelines. Finding notable discrepancies between the prescription practices and the guidelines would explain unjustified expenses in ARV therapy and the stockout problems and overstocks that occasionally occur.
August 2015 SIAPS/SCMS/BLC Newsletter
In this issue: Launch of Infection Prevention and Control Manuals, Creating Awareness on Antimicrobial Resistance and Rational Medicine Use Building the Supply Chain Capacity to Extend Health Services to the Community High Employer Satisfaction with Pharmacist Assistants Trained by the NHTC: A Tracer Study Reveals Improving Availability of ARVs at Primary Health Care Facilities in HIV/AIDS-Burdened Regions in Namibia Improving the Supply Chain Efficiency of Medical … Read more
El financiamiento de ARVs en República Dominicana
En el periodo 2004 a 2014, el financiamiento para la compra de antirretrovirales (ARVs) en República Dominicana recaía en proyectos del Fondo Mundial de lucha contra el SIDA, la Tuberculosis y la Malaria (Fondo Mundial). El Plan de Emergencia para el Alivio de Sida del Presidente de Estados Unidos (PEPFAR por sus siglas en inglés), … Read more
Quantification of HIV and AIDS Commodities for the Period April 2015 through March 2017, Swaziland
HIV and AIDS are the greatest public health and socio-economic development challenges for Swaziland. The Government of Swaziland (GOS) has made significant progress in addressing the epidemic through the implementation of a series of strategic plans and frameworks. Despite its efforts, Swaziland remains one of the countries with a high HIV disease burden. The extended … Read more
Angola: Better Patient Data, Better Supply Chain, Better Treatment Outcomes
The Problem In 2009, with the arrival of antiretroviral drugs (ARVs) c in Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR), Angolans living with HIV were given a lifeline for living longer, healthier, and more productive lives. As of 2012, there were a quarter of a million people in Angola living with HIV. … Read more
Antiretroviral Cohort Adverse Event Monitoring in KwaZulu-Natal
The high burden of HIV and the rapid scale up of ARV treatment program in KwaZulu-Natal provided a unique opportunity to establish a cohort event monitoring system at selected sites within the province. The aim of the cohort event monitoring study was to implement and establish a system of active surveillance that would have resulted … Read more
Training on ForLab and Long-Term Forecasting and Supply Planning of HIV and AIDS–Related Lab Commodities in Cameroon: Technical Report
A middle-income country in Central Africa, Cameroon had an HIV prevalence of 4.3% in 2011 in the general population 15–49 years of age (2011 DHS). The number of HIV patients on antiretroviral treatment (ART) has grown from a few hundred in 2001 to 78,000 at the end of 2009 and to 131,531 at the end … Read more
Strengthening Patient-centered Pharmacovigilance in South Africa
In an effort to strengthen national HIV/AIDS pharmacovigilance activities, the National Pharmacovigilance Center (NPC) has established a cost-effective way of promoting the safe, effective use of medicines in South Africa through the implementation of a decentralized pharmacovigilance program. This new initiative is being carried out with support from the Systems for Improved Access to Pharmaceuticals … Read more
Adverse Event Reporting on Antiretroviral Medicines in KwaZulu-Natal for April 2007 to March 2012
The advent of highly active antiretroviral therapy (HAART) has led to significant reductions in morbidity and mortality; however, adverse effects are common, and may lead to discontinuation of therapy, dose interuption, and significant reductions in quality of life. Prompt identification and management of adverse effects are crucial to ensuring adherence to treatment and the success … Read more
